CONSORT 2025: How to Critically Read and Report a Randomized Controlled Trial
A research-methods guide to randomization, allocation concealment, blinding, outcomes, harms, effect estimates and transparent RCT reporting using CONSORT 2025.
What You Should Be Able to Explain After Reading
- Use CONSORT 2025 concepts to appraise RCT reporting.
- Differentiate random sequence generation from allocation concealment.
- Interpret effect estimates with precision rather than p-values alone.
Why CONSORT matters
CONSORT is a reporting guideline, not a quality score. Better reporting helps readers understand what investigators planned, did, analysed and found, but appraisal still requires judgement about bias and applicability.
Randomization and concealment
Sequence generation creates an unpredictable allocation order. Allocation concealment prevents recruiters from knowing the upcoming assignment before enrolment. They solve different bias problems and should be reported separately.
What to inspect
- Eligibility criteria and setting.
- Prespecified primary and secondary outcomes.
- Randomization, concealment and who was blinded.
- Participant flow and missing data.
- Intervention and comparator detail sufficient for replication.
- Effect estimates with confidence intervals.
- Harms and unintended effects.
- Protocol/registration and deviations from planned analysis.
Clinical interpretation
Statistical significance does not tell you whether an effect is large enough to matter. Consider absolute between-group differences, confidence intervals, measurement properties, harms, burden and whether the participants resemble your patient population.
Common mistakes
- Calling a trial high quality because it says 'randomized'.
- Confusing allocation concealment with blinding.
- Reading only p-values.
- Ignoring attrition and protocol deviations.
- Assuming good reporting guarantees low risk of bias.
Clinical pearls
- Ask what was planned before asking what was significant.
- Follow participants from randomization to analysis.
- Read effect size and precision together.
Concise summary
CONSORT 2025 provides a transparent map of RCT reporting. Critical readers should connect trial design, participant flow, outcomes, effect estimates and harms before deciding whether results are credible and clinically useful.
Evidence & Further Reading
These sources are provided so learners can trace the clinical recommendations and read the original guidance.